Ritter O - Search Results

1

Soluble IL-33 receptor predicts survival in acute kidney injury.

Erfurt S, Hoffmeister M, Oess S, Asmus K, Patschan S, Ritter O, Patschan D. Erfurt S, et al. Among authors: ritter o. J Circ Biomark. 2022 Jun 6;11:28-35. doi: 10.33393/jcb.2022.2386. eCollection 2022 Jan-Dec. J Circ Biomark. 2022. PMID: 35707675 Free PMC article.

2

Secondary Prevention of Potentially Life-Threatening Arrhythmia Using Implantable Cardioverter Defibrillators in Patients with Biopsy-Proven Viral Myocarditis and Preserved Ejection Fraction.

Sasko B, Patschan D, Nordbeck P, Seidlmayer L, Andresen H, Jänsch M, Bramlage P, Ritter O, Pagonas N. Sasko B, et al. Among authors: ritter o. Cardiology. 2021;146(2):213-221. doi: 10.1159/000511120. Epub 2021 Feb 5. Cardiology. 2021. PMID: 33550300

3

Risk factors and outcome variables of cardiorenal syndrome type 1 from the nephrologist's perspective.

Seckinger D, Ritter O, Patschan D. Seckinger D, et al. Among authors: ritter o. Int Urol Nephrol. 2022 Jul;54(7):1591-1601. doi: 10.1007/s11255-021-03036-w. Epub 2021 Oct 28. Int Urol Nephrol. 2022. PMID: 34709558 Free PMC article.

4

Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?

Erfurt S, Hoffmeister M, Oess S, Asmus K, Ritter O, Patschan S, Patschan D. Erfurt S, et al. Among authors: ritter o. J Circ Biomark. 2021 Nov 30;10:20-25. doi: 10.33393/jcb.2021.2327. eCollection 2021 Jan-Dec. J Circ Biomark. 2021. PMID: 34858526 Free PMC article. Review.

5

Experimental Cardiorenal Syndrome Type 3: What Is Known so Far?

Patschan D, Marahrens B, Jansch M, Patschan S, Ritter O. Patschan D, et al. Among authors: ritter o. J Clin Med Res. 2022 Jan;14(1):22-27. doi: 10.14740/jocmr4639. Epub 2022 Jan 29. J Clin Med Res. 2022. PMID: 35211213 Free PMC article. Review.

6

Kidney Replacement Therapy in Cardiorenal Syndromes.

Patschan D, Drubel K, Matyukhin I, Marahrens B, Patschan S, Ritter O. Patschan D, et al. Among authors: ritter o. J Clin Med Res. 2022 Jul;14(7):264-272. doi: 10.14740/jocmr4676. Epub 2022 Jul 29. J Clin Med Res. 2022. PMID: 35974806 Free PMC article. Review.

7

Understanding the importance of social determinants and rurality for the long-term outcome after acute myocardial infarction: study protocol for a single-centre cohort study.

Sasko B, Jaehn P, Müller R, Andresen H, Müters S, Holmberg C, Ritter O, Pagonas N. Sasko B, et al. Among authors: ritter o. BMJ Open. 2022 Apr 15;12(4):e056888. doi: 10.1136/bmjopen-2021-056888. BMJ Open. 2022. PMID: 35428636 Free PMC article.

8

Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction.

Nahrendorf M, Spindler M, Hu K, Bauer L, Ritter O, Nordbeck P, Quaschning T, Hiller KH, Wallis J, Ertl G, Bauer WR, Neubauer S. Nahrendorf M, et al. Among authors: ritter o. Cardiovasc Res. 2005 Feb 1;65(2):419-27. doi: 10.1016/j.cardiores.2004.10.006. Cardiovasc Res. 2005. PMID: 15639481

9

Measuring RF-induced currents inside implants: Impact of device configuration on MRI safety of cardiac pacemaker leads.

Nordbeck P, Weiss I, Ehses P, Ritter O, Warmuth M, Fidler F, Herold V, Jakob PM, Ladd ME, Quick HH, Bauer WR. Nordbeck P, et al. Among authors: ritter o. Magn Reson Med. 2009 Mar;61(3):570-8. doi: 10.1002/mrm.21881. Magn Reson Med. 2009. PMID: 19132759 Free article.

10

Pacing lead inserted via the subclavian artery caused acute coronary syndrome.

Nordbeck P, Langenfeld H, Krein A, Bauer WR, Ritter O. Nordbeck P, et al. Among authors: ritter o. Herzschrittmacherther Elektrophysiol. 2008 Dec;19(4):188-92. doi: 10.1007/s00399-008-0016-3. Epub 2009 Feb 11. Herzschrittmacherther Elektrophysiol. 2008. PMID: 19214420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page